Univariate logistic regression analysis and multivariate logistic regression analysis of the relationships between riser pattern and variables
. | Univariate logistic regression . | Multivariate logistic regression . | ||
---|---|---|---|---|
Covariates . | Odds ratio (95% CI) . | P value . | Odds ratio (95% CI) . | P value . |
Age ≥ 65 years | 2.60 (1.18–5.71) | 0.02 | 3.24 (1.27–8.23) | 0.01 |
Men | 0.86 (0.48–1.53) | 0.60 | 0.71 (0.36–1.39) | 0.32 |
Body mass index ≥ 25 | 0.62 (0.33–1.14) | 0.13 | ||
Total cholesterol, mmol/L | 0.77 (0.54–1.11) | 0.16 | ||
Triglycerides, mmol/L | 0.93 (0.74–1.18) | 0.54 | ||
HDL cholesterol, mmol/L | 0.49 (0.23–1.05) | 0.06 | 0.45 (0.20–1.05) | 0.06 |
LDL cholesterol, mmol/L | 0.73 (0.48–1.13) | 0.15 | ||
Glucose, mmol/L | 0.87 (0.66–1.15) | 0.30 | ||
HbA1c, % | 1.13 (0.70–1.84) | 0.62 | ||
eGFR, ml/min/1.73 m2 | 0.98 (0.96–1.00) | 0.06 | ||
Chronic kidney disease | 1.67 (0.91–3.07) | 0.09 | 1.17 (0.58–2.33) | 0.66 |
Smokers | 1.10 (0.61–2.00) | 0.73 | ||
Dyslipidemia | 1.41 (0.60–3.28) | 0.43 | ||
Diabetes mellitus | 0.71 (0.35–1.45) | 0.35 | ||
Coronary heart disease | 0.85 (0.36–1.98) | 0.70 | ||
Cerebrovascular disease | 2.26 (1.03–4.97) | 0.04 | 1.96 (0.78–4.90) | 0.15 |
Sleep apnea syndrome | 0.74 (0.25–2.19) | 0.58 | ||
Primary aldosteronism | 0.96 (0.11–8.18) | 0.97 | ||
Bedtime dosing of antihypertensive drugs | 0.93 (0.51–1.67) | 0.80 | ||
Number of antihypertensive drugs | 1.02 (0.73–1.44) | 0.90 | ||
Office systolic blood pressure < 130 mm Hg | 1 (reference) | |||
Office systolic blood pressure 130–<140 mm Hg | 1.06 (0.54–2.11) | 0.86 | ||
Office systolic blood pressure ≥ 140 mm Hg | 0.91 (0.44–1.89) | 0.80 | ||
Morning systolic blood pressure < 125 mm Hg | 1 (reference) | |||
Morning systolic blood pressure 125–<135 mm Hg | 1.07 (0.55–2.10) | 0.84 | ||
Morning systolic blood pressure ≥ 135 mm Hg | 0.64 (0.31–1.33) | 0.23 | ||
Evening systolic blood pressure < 125 mm Hg | 1 (reference) | |||
Evening systolic blood pressure 125–<135 mm Hg | 0.23 (0.09–0.60) | 0.003 | 0.22 (0.08–0.58) | 0.002 |
Evening systolic blood pressure ≥ 135 mm Hg | 0.43 (0.19–0.96) | 0.04 | 0.39 (0.16–0.95) | 0.04 |
. | Univariate logistic regression . | Multivariate logistic regression . | ||
---|---|---|---|---|
Covariates . | Odds ratio (95% CI) . | P value . | Odds ratio (95% CI) . | P value . |
Age ≥ 65 years | 2.60 (1.18–5.71) | 0.02 | 3.24 (1.27–8.23) | 0.01 |
Men | 0.86 (0.48–1.53) | 0.60 | 0.71 (0.36–1.39) | 0.32 |
Body mass index ≥ 25 | 0.62 (0.33–1.14) | 0.13 | ||
Total cholesterol, mmol/L | 0.77 (0.54–1.11) | 0.16 | ||
Triglycerides, mmol/L | 0.93 (0.74–1.18) | 0.54 | ||
HDL cholesterol, mmol/L | 0.49 (0.23–1.05) | 0.06 | 0.45 (0.20–1.05) | 0.06 |
LDL cholesterol, mmol/L | 0.73 (0.48–1.13) | 0.15 | ||
Glucose, mmol/L | 0.87 (0.66–1.15) | 0.30 | ||
HbA1c, % | 1.13 (0.70–1.84) | 0.62 | ||
eGFR, ml/min/1.73 m2 | 0.98 (0.96–1.00) | 0.06 | ||
Chronic kidney disease | 1.67 (0.91–3.07) | 0.09 | 1.17 (0.58–2.33) | 0.66 |
Smokers | 1.10 (0.61–2.00) | 0.73 | ||
Dyslipidemia | 1.41 (0.60–3.28) | 0.43 | ||
Diabetes mellitus | 0.71 (0.35–1.45) | 0.35 | ||
Coronary heart disease | 0.85 (0.36–1.98) | 0.70 | ||
Cerebrovascular disease | 2.26 (1.03–4.97) | 0.04 | 1.96 (0.78–4.90) | 0.15 |
Sleep apnea syndrome | 0.74 (0.25–2.19) | 0.58 | ||
Primary aldosteronism | 0.96 (0.11–8.18) | 0.97 | ||
Bedtime dosing of antihypertensive drugs | 0.93 (0.51–1.67) | 0.80 | ||
Number of antihypertensive drugs | 1.02 (0.73–1.44) | 0.90 | ||
Office systolic blood pressure < 130 mm Hg | 1 (reference) | |||
Office systolic blood pressure 130–<140 mm Hg | 1.06 (0.54–2.11) | 0.86 | ||
Office systolic blood pressure ≥ 140 mm Hg | 0.91 (0.44–1.89) | 0.80 | ||
Morning systolic blood pressure < 125 mm Hg | 1 (reference) | |||
Morning systolic blood pressure 125–<135 mm Hg | 1.07 (0.55–2.10) | 0.84 | ||
Morning systolic blood pressure ≥ 135 mm Hg | 0.64 (0.31–1.33) | 0.23 | ||
Evening systolic blood pressure < 125 mm Hg | 1 (reference) | |||
Evening systolic blood pressure 125–<135 mm Hg | 0.23 (0.09–0.60) | 0.003 | 0.22 (0.08–0.58) | 0.002 |
Evening systolic blood pressure ≥ 135 mm Hg | 0.43 (0.19–0.96) | 0.04 | 0.39 (0.16–0.95) | 0.04 |
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein; eGFR, estimated glomerular filtration rate.
Univariate logistic regression analysis and multivariate logistic regression analysis of the relationships between riser pattern and variables
. | Univariate logistic regression . | Multivariate logistic regression . | ||
---|---|---|---|---|
Covariates . | Odds ratio (95% CI) . | P value . | Odds ratio (95% CI) . | P value . |
Age ≥ 65 years | 2.60 (1.18–5.71) | 0.02 | 3.24 (1.27–8.23) | 0.01 |
Men | 0.86 (0.48–1.53) | 0.60 | 0.71 (0.36–1.39) | 0.32 |
Body mass index ≥ 25 | 0.62 (0.33–1.14) | 0.13 | ||
Total cholesterol, mmol/L | 0.77 (0.54–1.11) | 0.16 | ||
Triglycerides, mmol/L | 0.93 (0.74–1.18) | 0.54 | ||
HDL cholesterol, mmol/L | 0.49 (0.23–1.05) | 0.06 | 0.45 (0.20–1.05) | 0.06 |
LDL cholesterol, mmol/L | 0.73 (0.48–1.13) | 0.15 | ||
Glucose, mmol/L | 0.87 (0.66–1.15) | 0.30 | ||
HbA1c, % | 1.13 (0.70–1.84) | 0.62 | ||
eGFR, ml/min/1.73 m2 | 0.98 (0.96–1.00) | 0.06 | ||
Chronic kidney disease | 1.67 (0.91–3.07) | 0.09 | 1.17 (0.58–2.33) | 0.66 |
Smokers | 1.10 (0.61–2.00) | 0.73 | ||
Dyslipidemia | 1.41 (0.60–3.28) | 0.43 | ||
Diabetes mellitus | 0.71 (0.35–1.45) | 0.35 | ||
Coronary heart disease | 0.85 (0.36–1.98) | 0.70 | ||
Cerebrovascular disease | 2.26 (1.03–4.97) | 0.04 | 1.96 (0.78–4.90) | 0.15 |
Sleep apnea syndrome | 0.74 (0.25–2.19) | 0.58 | ||
Primary aldosteronism | 0.96 (0.11–8.18) | 0.97 | ||
Bedtime dosing of antihypertensive drugs | 0.93 (0.51–1.67) | 0.80 | ||
Number of antihypertensive drugs | 1.02 (0.73–1.44) | 0.90 | ||
Office systolic blood pressure < 130 mm Hg | 1 (reference) | |||
Office systolic blood pressure 130–<140 mm Hg | 1.06 (0.54–2.11) | 0.86 | ||
Office systolic blood pressure ≥ 140 mm Hg | 0.91 (0.44–1.89) | 0.80 | ||
Morning systolic blood pressure < 125 mm Hg | 1 (reference) | |||
Morning systolic blood pressure 125–<135 mm Hg | 1.07 (0.55–2.10) | 0.84 | ||
Morning systolic blood pressure ≥ 135 mm Hg | 0.64 (0.31–1.33) | 0.23 | ||
Evening systolic blood pressure < 125 mm Hg | 1 (reference) | |||
Evening systolic blood pressure 125–<135 mm Hg | 0.23 (0.09–0.60) | 0.003 | 0.22 (0.08–0.58) | 0.002 |
Evening systolic blood pressure ≥ 135 mm Hg | 0.43 (0.19–0.96) | 0.04 | 0.39 (0.16–0.95) | 0.04 |
. | Univariate logistic regression . | Multivariate logistic regression . | ||
---|---|---|---|---|
Covariates . | Odds ratio (95% CI) . | P value . | Odds ratio (95% CI) . | P value . |
Age ≥ 65 years | 2.60 (1.18–5.71) | 0.02 | 3.24 (1.27–8.23) | 0.01 |
Men | 0.86 (0.48–1.53) | 0.60 | 0.71 (0.36–1.39) | 0.32 |
Body mass index ≥ 25 | 0.62 (0.33–1.14) | 0.13 | ||
Total cholesterol, mmol/L | 0.77 (0.54–1.11) | 0.16 | ||
Triglycerides, mmol/L | 0.93 (0.74–1.18) | 0.54 | ||
HDL cholesterol, mmol/L | 0.49 (0.23–1.05) | 0.06 | 0.45 (0.20–1.05) | 0.06 |
LDL cholesterol, mmol/L | 0.73 (0.48–1.13) | 0.15 | ||
Glucose, mmol/L | 0.87 (0.66–1.15) | 0.30 | ||
HbA1c, % | 1.13 (0.70–1.84) | 0.62 | ||
eGFR, ml/min/1.73 m2 | 0.98 (0.96–1.00) | 0.06 | ||
Chronic kidney disease | 1.67 (0.91–3.07) | 0.09 | 1.17 (0.58–2.33) | 0.66 |
Smokers | 1.10 (0.61–2.00) | 0.73 | ||
Dyslipidemia | 1.41 (0.60–3.28) | 0.43 | ||
Diabetes mellitus | 0.71 (0.35–1.45) | 0.35 | ||
Coronary heart disease | 0.85 (0.36–1.98) | 0.70 | ||
Cerebrovascular disease | 2.26 (1.03–4.97) | 0.04 | 1.96 (0.78–4.90) | 0.15 |
Sleep apnea syndrome | 0.74 (0.25–2.19) | 0.58 | ||
Primary aldosteronism | 0.96 (0.11–8.18) | 0.97 | ||
Bedtime dosing of antihypertensive drugs | 0.93 (0.51–1.67) | 0.80 | ||
Number of antihypertensive drugs | 1.02 (0.73–1.44) | 0.90 | ||
Office systolic blood pressure < 130 mm Hg | 1 (reference) | |||
Office systolic blood pressure 130–<140 mm Hg | 1.06 (0.54–2.11) | 0.86 | ||
Office systolic blood pressure ≥ 140 mm Hg | 0.91 (0.44–1.89) | 0.80 | ||
Morning systolic blood pressure < 125 mm Hg | 1 (reference) | |||
Morning systolic blood pressure 125–<135 mm Hg | 1.07 (0.55–2.10) | 0.84 | ||
Morning systolic blood pressure ≥ 135 mm Hg | 0.64 (0.31–1.33) | 0.23 | ||
Evening systolic blood pressure < 125 mm Hg | 1 (reference) | |||
Evening systolic blood pressure 125–<135 mm Hg | 0.23 (0.09–0.60) | 0.003 | 0.22 (0.08–0.58) | 0.002 |
Evening systolic blood pressure ≥ 135 mm Hg | 0.43 (0.19–0.96) | 0.04 | 0.39 (0.16–0.95) | 0.04 |
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein; eGFR, estimated glomerular filtration rate.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.